Summation (formerly World of DaaS) Martin Shkreli on prison, beating Bloomberg, and being hated
57 snips
Feb 11, 2026 
Martin Shkreli, entrepreneur known for founding Turing Pharmaceuticals and DL Software, discusses building a Bloomberg competitor and why financial terminals resist competition. He talks about running drug programs remotely, including from prison. Topics include AI recruiting top quant talent, private-market data and trading, prosecutorial power in corporate cases, and the media dynamics of being widely despised.
AI Snips
Chapters
Transcript
Episode notes
Media Drives High‑Profile Prosecutions
- High‑profile tech prosecutions often reflect media pressure and institutional incentives as much as objective criminality.
- Public attention can drive prosecutors to pursue showy cases over street‑level crime.
Failure Vs. Criminality In Business
- Many spectacular business failures invite criminalization even when failure, not crime, is the core issue.
- Trials and media narratives often shape public judgment more than technical business realities.
Limit Position Size To Avoid Greed Risk
- Avoid oversized positions and cap downside with hedges or position sizing rules like Kelly/quarter‑Kelly.
- Force discipline: if a loss threshold is hit, exit to avoid greedy ruin.